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OBJECTIVE — We developed a new method of estimating visceral fat area (VFA) using
multifrequency bioelectrical impedance (BI).
RESEARCH DESIGN AND METHODS — We considered abdominal composition as a
parallelcircuitmodelcomposedofVFAandsubcutaneousfatareaandcalculatedtheimpedance
ofVFA(IPVFA)fromthismodel.ThemethodsweretestedagainstmeasuresofVFAbycomputed
tomography (CT). Multiple regression analysis was performed on 103 participants to estimate
VFA. We cross-validated the regression equation against CT-measured VFA in 30 additional
participants.
RESULTS — The regression equation was VFA  3.57  sagittal abdominal diameter 
311.97  waist-to-height ratio  0.71  age  23.93  sex  1.57  IPVFA (250 kHz) 
174.35(r0.904,P0.01).Weobservedastrongcorrelationbycross-validation(r0.905).
CONCLUSIONS — Our method using BI is a simple and convenient method for accurately
estimating VFA.
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T
he accumulation of visceral fat area
(VFA) induces several health risks
(1–3), thus there is a need for a sim-
ple method of determining how much
VFA has accumulated. The efﬁcacies for
estimating VFA using bioelectrical im-
pedance (BI) have been reported (4–6).
Because such studies found that the ob-
tained impedance differed according to
body posture (7–9), electrode arrange-
ment (10,11), and frequency (12), we
previously developed a method of esti-
mating VFA using BI by selecting appro-
priate measurement conditions (13).
However, we could not eliminate the ef-
fect of subcutaneous fat area (SFA). In the
present study, we overcame this problem
and developed a new method of estimat-
ing VFA using BI.
RESEARCH DESIGN AND
METHODS— We recruited 84 men
and 49 women, aged 20–67 years, from
among the students and teaching and ad-
ministrative staff at our university. All
participants were fully informed of the
procedures, risk, and discomfort. The
study protocol was approved by the bio-
ethics committee of Utsunomiya
University.
The details of the study method have
been described previously (13). Brieﬂy,
we measured anthropometry parameters.
BMI was calculated as body weight (in ki-
lograms) divided by the square of height
(inmeters).Waist-to-heightratio(WHtR)
and waist-to-hip ratio were calculated as
waist circumference (W) divided by
height and by hip circumference, respec-
tively. We took computed tomography
(CT) at the umbilical level and calculated
VFA and SFA using the image analysis
softwareFatScanversion3.0(N2System,
Hyogo, Japan). The methods were tested
against measures of VFA by CT. We mea-
sured impedance by the tetrapolar im-
pedance method using multifrequency BI
(MFBIA-07; Tanita, Tokyo, Japan). The
repeatability of this device was conﬁrmed
inthesameparticipants(datanotshown).
We measured impedance more than 2 h
after exercise, eating, and drinking. Im-
pedance was measured at the frequencies
of 5, 25, 50, 100, and 250 kHz in the
supine posture, and the value measured
theﬁrsttimewasused.Weusedtwotypes
ofelectrodearrangement.First,weplaced
sensing electrodes symmetrically about
the body axis, at a separation of 10 cm.
Current electrodes were placed to the
right and left of the sensing electrodes.
The distance between the current elec-
trodes and sensing electrodes was 10 cm
(13). From this electrode arrangement,
we obtained the impedance of the whole
abdomen (IPVFASFA). After measuring
IPVFASFA, we brought the right sensing
electrode closer to the right current elec-
trode, to 3 cm. From this electrode ar-
rangement,weobtainedtheimpedanceof
SFA(IPSFA)fromjustundertheskin(10).
In this study, we considered abdominal
composition as a parallel circuit model
composedofVFAandSFA.Wecalculated
the impedance of VFA (IPVFA) for each
frequency as IPVFA  (IPVFASFA 
IPSFA)/(IPVFASFA  IPSFA).
Statistical analysis
We randomly assigned participants into
two groups, one composed of 103 partic-
ipants and the other of 30 participants.
Stepwise multiple regression analysis was
performed on the 103 participants to es-
timate VFA. Their mean BMI and VFA by
CT were 22.67 kg/m
2 (range 17.19–
34.07) and 51.71 cm
2 (5.55–212.20), re-
spectively. Independent variables were
sex, age, anthropometry parameters, and
IPVFA at each frequency. We cross-
validated the regression equation against
CT-measured VFA in 30 additional par-
ticipants (VFA range 12.6–159.1 cm
2).
The Bland-Altman method was used to
examinethemeandifferenceand1.96SD
between VFA observed by CT and that
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
From the
1Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku Univer-
sity Graduate School of Medicine, Sendai, Japan; the
2Department of Exercise Physiology, Utsunomiya
University, Tochigi, Japan; the
3Department of Public Health, School of Medicine, Dokkyo University,
Tochigi, Japan; the
4Division of Diabetes and Endocrinology, Department of Internal Medicine, Jikei
University Daisan Hospital, Tokyo, Japan; the
5Department of Internal Medicine, Sirasawa Hospital,
Tochigi, Japan; and the
6Tanita Body Weight Scientiﬁc Institute, Tokyo, Japan.
Corresponding author: Hideaki Komiya, komiya@cc.utsunomiya-u.ac.jp.
Received 17 June 2009 and accepted 5 February 2010. Published ahead of print at http://care.
diabetesjournals.org on 11 February 2010. DOI: 10.2337/dc09-1099.
© 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Emerging Treatments and Technologies
BRIEF REPORT
care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 5, MAY 2010 1077estimated by IPVFA (14). We calculated
the sensitivity and speciﬁcity at VFA
100 cm
2 by the regression equation
(15). The correlation between impedance
and VFA and SFA was examined by Pear-
son correlation coefﬁcient. All P values
were two-tailed, and P  0.05 was ac-
cepted as statistically signiﬁcant.
RESULTS— The weakest and stron-
gest correlation between impedance ob-
tainedattheﬁvefrequenciesandVFAand
SFA were r  0.734–0.747 (IPVFA) and
r  0.834–0.872 (IPSFA), respectively.
The regression equation was VFA 
3.57  sagittal abdominal diameter 
311.97  WHtR  0.71  age 
23.93sex1.57IPVFA(250kHz)
174.35 (r  0.904, P  0.01) (Fig. 1).
Also, we observed a strong correla-
tion in the cross-validation subsample
(r  0.905, P  0.01). The Bland-Altman
method showed a mean difference and
1.96 SD of 0.00  40.78 cm
2. There was
no increasing bias for heavier partici-
pants. We observed a high sensitivity and
speciﬁcity (0.941 and 0.988, respec-
tively)whenwediscriminatedVFA100
cm
2 or100 cm
2by the regression equa-
tion. Meanwhile, waist circumference
(W) at the umbilicus level (men: W 85
cm, women: W 90 cm) is used for
screening of VFA 100 cm
2 in Japan
(15), thus sensitivity and speciﬁcity were
0.882 and 0.919, respectively, by W in
our participants.
CONCLUSIONS— In this study, be-
cause subcutaneous fat layer thickness af-
fected the impedance when electrodes
were placed on the abdomen (6), we con-
sidered abdominal composition as a par-
allel circuit model and calculated IPVFA
using the formula for a parallel circuit.
Therefore,weeliminatedtheeffectofSFA
by this model.
In Japan, waist circumference at the
umbilicus level was used to screen for
VFA 100 cm
2 because CT has some
problems such as radiation exposure
(15). However, our regression equation
demonstratedhighersensitivityandspec-
iﬁcity than waist circumference.
A major strength of our study is that
the number of study participants was
more than in any previous study (4–
6,13). Additionally, we cross-validated
the regression equation and obtained a
strong correlation (r  0.905, P  0.01).
On the other hand, our study has several
limitations. First, the study participants
wereyoung(meanageSD:30.310.8
years), and the proportion of VFA 100
cm
2 was small (16.5%), so we may not be
able to adapt this regression equation for
middle-aged people who have a higher
proportionofVFA100cm
2thanyoung
people.Second,thedataarelimitedtothe
Japanesepopulation,whichmayhavedif-
ferent VFA characteristics than other
populations.
Our new method using BI is a simple
and convenient method for accurately es-
timatingVFA.Wecaneasilyscreenexcess
accumulation of VFA, which is associated
with metabolic syndrome. The method
may be a useful tool for primary preven-
tion of metabolic syndrome.
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